Iron Deficiency Anemia vs Anemia of Chronic Disease
Both are common causes of anemia with a low serum iron, and both can produce small red cells—making them a classic USMLE trap. The core axis that separates them is the iron storage pattern: in iron deficiency, stores are truly depleted (low ferritin, high TIBC), whereas in anemia of chronic disease, hepcidin traps abundant iron inside macrophages (high ferritin, low/normal TIBC).
How to tell them apart
| Feature | Iron deficiency anemia | Anemia of chronic disease |
|---|---|---|
| MCV | Microcytic (MCV <80 fL); heme cannot be made, so cells divide extra times waiting for hemoglobin | Usually normocytic; becomes microcytic only in long-standing inflammation |
| Ferritin (iron stores) | Low — stores are depleted, the defining feature | High or normal — stores remain full, iron is simply sequestered |
| TIBC | High — the body upregulates transport capacity to scavenge iron | Low or normal |
| Underlying mechanism | Depleted total body iron from blood loss or inadequate intake | Chronic inflammation → IL-6 → hepcidin degrades ferroportin → iron trapped in macrophages and enterocytes, plus a blunted EPO response and shortened RBC lifespan |
| Serum erythropoietin | Elevated (appropriate response to anemia) | Inappropriately low/blunted for the degree of anemia |
| Soluble transferrin receptor | Elevated | Not elevated |
| Peripheral smear | Microcytic, hypochromic cells with anisocytosis, poikilocytosis, and pencil (cigar) cells | Less specific; lacks the marked hypochromia and pencil cells of iron deficiency |
| Typical clinical context | Premenopausal woman with heavy menses or poor dietary intake; GI blood loss in men and postmenopausal women | Chronic inflammatory illness such as rheumatoid arthritis, or malignancy such as Hodgkin lymphoma |
The reasoning
When you see a low serum iron, do not stop—both conditions share it. Anchor on ferritin and TIBC. A low ferritin with a high TIBC means empty stores: iron deficiency. A high (or normal) ferritin with a low TIBC means iron is present but locked away by hepcidin: anemia of chronic disease. Reinforce the impression with context (bleeding or dietary deficit versus an active inflammatory disease), the smear (hypochromic microcytes with pencil cells favor iron deficiency), and ancillary tests (elevated soluble transferrin receptor and EPO point to iron deficiency; a blunted EPO points to chronic disease). In iron deficiency in a man or postmenopausal woman, the next step is not simply iron replacement but identifying the source—exclude GI malignancy with endoscopy.
Key tests
- Ferritin: low in iron deficiency, high/normal in anemia of chronic disease — the single most useful discriminator
- TIBC: elevated in iron deficiency, low/normal in anemia of chronic disease
- Serum soluble transferrin receptor: elevated in iron deficiency, normal in anemia of chronic disease
- Serum erythropoietin: elevated in iron deficiency, inappropriately low in anemia of chronic disease
What they share
- Present with fatigue and symptoms of anemia
- Low serum iron on iron studies
- Both can be microcytic (iron deficiency always; anemia of chronic disease in long-standing cases)
- Both fall under underproduction anemias with a low reticulocyte response
Pitfalls
- Anchoring on the shared low serum iron and forgetting that ferritin and TIBC are what separate the two.
- Ferritin behaves as an acute-phase reactant, so it can be normal or high in inflammation and mask a coexisting iron deficiency in a patient with chronic disease.
- Assuming anemia of chronic disease is always normocytic—long-standing inflammation can drive it microcytic, mimicking iron deficiency.
- Premature closure: attributing iron deficiency to menses or diet without pursuing GI blood loss, especially in men and postmenopausal women.
- Mistaking normal iron studies for either diagnosis—normal ferritin, iron, and TIBC with a high RBC count and normal RDW points instead to thalassemia minor, which is also the classic setting for target cells on smear.
Practice this the way the exam tests it — on branching cases where your decisions shape the patient.